Xeltis

Developer of bioabsorbable synthetic heart valves and vascular grafts

placeZurich, Zurich, Switzerland calendar_todayFounded 2006 groups68 employees language xeltis.com

Innovation

9 patent families (5 granted) — focus: Human necessities, Textiles & paper; filing pace slowing. Cited 266 times.

YearFilings
20151
20161
20173
20185
20195
20206
20221

Social engagement

Social engagement: 9.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record; lead investors include China Grand Pharmaceutical and Healthcare, DaVita Venture Group, EQT, Invest-NL.

Investor typeCountShare
Venture capital747%
Private equity320%
Accelerator & incubator17%
Other / undisclosed427%

Recent activity

2 Jul 2026
Milestone
regulatory
18 Jun 2026
Event
American Association of Kidney Patients Healthline Innovator Webinar
12 Jun 2026
Event
AAKP Global Summit on Kidney Disease Innovations
Coming soon